Comparison between EP Biocomposites IPO and Rhetan TMT IPO.
EP Biocomposites IPO is a SME Fixed Price IPO proposed to list at BSE SME while Rhetan TMT IPO is a SME Fixed Price proposed to list at BSE SME.
| EP Biocomposites IPO | Rhetan TMT IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Aryaman Financial Services Ltd. | Aryaman Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Aryaman Capital Markets Ltd. | Aryaman Capital Markets Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of EP Biocomposites IPO is up to ₹6.00 Cr whereas the issue size of the Rhetan TMT IPO is up to ₹53.09 Cr. The final issue price of EP Biocomposites IPO is ₹126.00 per share and of Rhetan TMT IPO is ₹70.00 per share.
| EP Biocomposites IPO | Rhetan TMT IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹126.00 per share | ₹70.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1000 shares | 2000 shares |
| Fresh Issue Size | 4,76,000 shares | 75,84,000 shares |
| Fresh Issue Size (Amount) | up to ₹6.00 Cr | up to ₹53.09 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 4,76,000 shares | 75,84,000 shares |
| Issue Size Total (Amount) | up to ₹6.00 Cr | up to ₹53.09 Cr |
EP Biocomposites IPO opens on Aug 29, 2022, while Rhetan TMT IPO opens on Aug 22, 2022. The closing date of EP Biocomposites IPO and Rhetan TMT IPO is Sep 05, 2022, and Aug 25, 2022, respectively.
| EP Biocomposites IPO | Rhetan TMT IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2022 | Aug 22, 2022 |
| Issue Close | Sep 05, 2022 | Aug 25, 2022 |
| Basis Of Allotment (Tentative) | Sep 08, 2022 | Aug 30, 2022 |
| Initiation of Refunds (Tentative) | Sep 09, 2022 | Sep 01, 2022 |
| Credit of Share (Tentative) | Sep 12, 2022 | Sep 02, 2022 |
| Listing date (Tentative) | Sep 13, 2022 | Sep 05, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
EP Biocomposites IPO P/E ratio is 26.2, as compared to Rhetan TMT IPO P/E ratio of 63.64.
| EP Biocomposites IPO | Rhetan TMT IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 98.97 | 99.62 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 69.40 | 62.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 26.2 | 63.64 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.19 Cr. | ₹148.75 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.15 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹9.48 | ₹2.00 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 40.5 | 10.14 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the EP Biocomposites IPO Retail Individual Investors (RII) are offered 2,38,000 shares while in Rhetan TMT IPO retail investors are offered 2,38,000 shares. Qualified Institutional Buyers (QIB) are offered in EP Biocomposites IPO and in Rhetan TMT IPO.
| EP Biocomposites IPO | Rhetan TMT IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 28,000 shares | 4,16,000 shares |
| QIB | ||
| NII | 2,38,000 shares | 37,92,000 shares |
| RII | 2,38,000 shares | 37,92,000 shares |
| Employee | ||
| Others | ||
| Total | 4,76,000 shares | 75,84,000 shares |
EP Biocomposites IPO subscribed 18.51x in total, whereas Rhetan TMT IPO subscribed 1.47x.
| EP Biocomposites IPO | Rhetan TMT IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 21.58x | 2.18x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 15.44x | 0.76x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 18.51x | 1.47x |
